Transfusion management in the era of magrolimab (<scp>Hu5F9‐G4</scp>), an anti‐<scp>CD47</scp> monoclonal antibody therapy-Reference-Cited by-同舟云学术

Transfusion management in the era of magrolimab (Hu5F9‐G4), an anti‐CD47 monoclonal antibody therapy

Published:2023-11-16 Issue:12 Volume:63 Page:2377-2383
ISSN:0041-1132
Container-title:Transfusion
language:en
Short-container-title:Transfusion

Author:

Singh Nirupama¹,Staves Julie²,Storry Jill R.³^ORCID,Dinoso Jason⁴,Renard Camille⁴,Doshi Parul⁴,Johnson Lisa D.S.⁴^ORCID,Westhoff Connie M.⁵^ORCID,Murphy Michael F.⁶^ORCID

Affiliation:

1. Department of Pathology The University of Alabama at Birmingham Birmingham Alabama USA

2. Oxford University Hospitals, NHS Foundation Trust Oxford UK

3. Division of Hematology and Transfusion Medicine Lund University Lund Sweden

4. Gilead Sciences, Inc Foster City California USA

5. New York Blood Center Enterprises, Immunohematology and Blood Group Genomics New York New York USA

6. NHS Blood and Transplant, Oxford University Hospitals NHS Foundation Trust and the University of Oxford Oxford UK

Funder

Gilead Sciences

Publisher

Wiley

Subject

Hematology,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/trf.17597

Reference50 articles.

1. Resolving the daratumumab interference with blood compatibility testing

2. Transfusion management for patients taking an anti‐CD38 monoclonal antibody;Bub CB;Rev Bras Hematol Hemoter,2018

3. When blood transfusion medicine becomes complicated due to interference by monoclonal antibody therapy

4. Overcoming Drug Interference in Transfusion Testing: A Spotlight on Daratumumab

5. Therapeutic opportunities for targeting the ubiquitous cell surface receptor CD47

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interference of Monoclonal Antibody Therapy in Transfusion: An Update;Hemato;2024-07-02

2. How do transfusion services manage patients taking therapies such as anti‐CD38 and anti‐CD47 known to interfere with red blood cell compatibility testing?;Transfusion;2024-05-20